Cargando…

The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran

Dabigatran is an oral direct thrombin inhibitor (DTI) licensed for stroke prevention in atrial fibrillation and likely to be soon approved in Europe for treatment of venous thrombosis. Predictable pharmacokinetics and a reduced risk of intracranial haemorrhage do not negate the potential risk of hae...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alikhan, Raza, Rayment, Rachel, Keeling, David, Baglin, Trevor, Benson, Gary, Green, Laura, Marshall, Scott, Patel, Raj, Pavord, Sue, Rose, Peter, Tait, Campbell
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913117/ https://www.ncbi.nlm.nih.gov/pubmed/23435652 http://dx.doi.org/10.1136/emermed-2012-201976

Ejemplares similares

Venovenous haemodiafiltration for the management of dabigatran overdose in intensive care unit
por: Claisse, Guillaume, et al.
Publicado: (2015)

Hip arthroplasty fatality related to dabigatran induced gastrointestinal haemorrhage
por: Carter, A, et al.
Publicado: (2014)

Warfarin overdose: Intracerebral haemorrhage: case report
Publicado: (2021)

Fibrinogen concentrate versus placebo for treatment of postpartum haemorrhage: study protocol for a randomised controlled trial
por: Aawar, Nadine, et al.
Publicado: (2015)

Dabigatran Acylglucuronide, the Major Metabolite of Dabigatran, Shows a Weaker Anticoagulant Effect than Dabigatran
por: Kim, Jong-Min, et al.
Publicado: (2022)

Additive effect of dabigatran and high-dose aspirin in the development of haemorrhagic pleural effusion in a patient with tuberculous pleuritis
por: Karagül, Duygu Acar, et al.
Publicado: (2020)

A case of ChAdOx1 vaccine-induced thrombocytopenia and thrombosis syndrome leading to bilateral adrenal haemorrhage and adrenal insufficiency
por: Efthymiadis, Agathoklis, et al.
Publicado: (2022)

Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Thrombolytic Therapy
por: Kikule, Ilga, et al.
Publicado: (2022)

The Dabigatran debate
por: Kaba, Riyaz A, et al.
Publicado: (2014)

The Discovery of Dabigatran Etexilate
por: van Ryn, Joanne, et al.
Publicado: (2013)

Dabigatran and apolipoprotein B
por: ten Cate, Hugo
Publicado: (2016)

The Renal Elimination Pathways of the Dabigatran Reversal Agent Idarucizumab and its Impact on Dabigatran Elimination
por: Glund, Stephan, et al.
Publicado: (2018)

A three-year prospective study of the presentation and clinical outcomes of major bleeding episodes associated with oral anticoagulant use in the UK (ORANGE study)
por: Green, Laura, et al.
Publicado: (2018)

Cost of dabigatran for atrial fibrillation
por: Gage, Brian F
Publicado: (2011)

Dabigatran etexilate tetrahydrate
por: Liu, Hong-Qiang, et al.
Publicado: (2012)

Pharmacometric Characterization of Dabigatran Hemodialysis
por: Liesenfeld, Karl-Heinz, et al.
Publicado: (2013)

Dabigatran for left atrial thrombus
por: Morita, Sae, et al.
Publicado: (2013)

Promise and challenges of anticoagulation with dabigatran
por: Verma, Ashish, et al.
Publicado: (2012)

Dabigatran Associated Leukocytoclastic Vasculitis
por: Potolidis, Evangelos, et al.
Publicado: (2015)

Interstitial pneumonia caused by dabigatran
por: Yanagihara, Toyoshi, et al.
Publicado: (2017)

Possible renoprotective effects of dabigatran
por: Karahan, Oğuz
Publicado: (2015)

Bilateral Pulmonary Emboli on Dabigatran
por: Clark, Emily, et al.
Publicado: (2021)

Pharmacokinetics of idarucizumab and its target dabigatran in patients requiring urgent reversal of the anticoagulant effect of dabigatran
por: Glund, Stephan, et al.
Publicado: (2019)

Management of Massive Rivaroxaban Overdose With Acetaminophen and Isosorbide Mononitrate Overdose
por: Casey, Bradley, et al.
Publicado: (2023)

Rationale and design of a phase III safety trial of idarucizumab in children receiving dabigatran etexilate for venous thromboembolism
por: Albisetti, Manuela, et al.
Publicado: (2017)

Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Alteplase: A Systematic Review of the Available Evidence
por: Pikija, Slaven, et al.
Publicado: (2017)

Predicting accidental drug overdose as the cause of fatality in near real-time using the Suspected Potential Overdose Tracker (SPOT): public health implications
por: Hochstatter, Karli R., et al.
Publicado: (2022)

41538 Characterizing Opioid Overdose Hotspots for Targeted Overdose Prevention and Treatment
por: Samuels, Elizabeth A., et al.
Publicado: (2021)

Anticoagulant Related Nephropathy Induced by Dabigatran
por: Sharfuddin, Nazia, et al.
Publicado: (2018)

Dabigatran-Induced Massive Spontaneous Hemothorax
por: Huang, Jing, et al.
Publicado: (2017)

Idarucizumab for the treatment of dabigatran-related nephropathy
por: Alsamarrai, Ammar, et al.
Publicado: (2020)

Impact of Dabigatran Treatment on Rotation Thromboelastometry
por: Sokol, Juraj, et al.
Publicado: (2021)

Overdose Detection Technologies to Reduce Solitary Overdose Deaths: A Literature Review
por: Lombardi, Alexa Rose, et al.
Publicado: (2023)

Virtual overdose monitoring services: a novel adjunctive harm reduction approach for addressing the overdose crisis
por: Matskiv, George, et al.
Publicado: (2022)

Sub-Arachnoid Hæmorrhage
por: Campbell, S. B. Boyd
Publicado: (1932)

Biphasic Effects of Naloxone in the Rats Receiving Morphine Overdose A Place Preference Study
por: Karimi, Sara, et al.
Publicado: (2011)

Benzodiazepine prescribing patterns and drug overdose mortality among individuals receiving opioid analgesics
por: Park, Tae Woo, et al.
Publicado: (2015)

Overdose /
por: Sarduy, Severo

Overdosed
por: Thangarasa, Tharshika, et al.
Publicado: (2018)

New options with dabigatran etexilate in anticoagulant therapy
por: Maegdefessel, Lars, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_uodb9tgoibsa38dabqdkmor2c1